REGULATORY
Deregulation Panel Proposes Giving Private Companies Access to National Health Database to Promote New Drug Development
The Regulatory Reform Promotion Council issued on June 6 its recommendation to Prime Minister Shinzo Abe, calling for the provisioning of data from the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) to private companies…
To read the full story
Related Article
- Deregulation Panel Pushes PMDA to Digitalize Process
June 6, 2018
REGULATORY
- Pharma Urges Pricing Rewards to Bolster Japan’s Drug Discovery Strength
September 24, 2026
- Nippon Ishin’s Urano Named Senior Vice Health Minister in Takaichi Cabinet
September 24, 2026
- Ueno Vows to Advance Drug Innovation, Advanced Medicine in 2nd Term
September 24, 2026
- Officer Replacement Orders a “Last Resort” under PMD Act: MHLW Official
September 18, 2026
- Japan Panel Sees No Scientific Objection to Capvaxive NIP Addition
September 18, 2026
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…





